Answers are grounded in this paper and cite their sources.
mutation cannot be used as a single, independent predictive factor. However, its usefulness in the context of other molecular and clinico-pathological risk factors cannot be excluded. They may be used to make modern prognostic scales of relapse risk and be applied to individualized diagnostic and therapeutic strategy for PTC patients.
No takes yet. Share an insight, caveat, or question.
Czarniecka et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: